Why Metrion’s CSO spent 35 years unlocking the potential of ion channels for drug discovery

By |November 6th, 2019|Categories: Blog|Tags: , , , , , , , , |

Thank you to the ELRIG Committee and to BioStrata for allowing us to share the below content on our website. The British Pharmacological Society (BPS) ran a special [...]

Opportunities for Ion Channel Targeting Antibodies: Current Landscape and Pipeline

By |August 28th, 2019|Categories: Blog|Tags: , , , , , , , |

Overview Metrion Biosciences’ tenth External Speaker Series presentation featured Dr Catherine Hutchings, a highly experienced biologics drug discovery researcher and independent consultant. Dr Hutchings’ presentation included an [...]

ELRIG: Advances in Cell Based Screening – Gothenburg, Sweden

By |July 2nd, 2019|Categories: Blog|Tags: , , , , , , |

ELRIG is a not-for-profit organisation aiming to provide access to high level scientific content, promote innovation in drug discovery and provide networking platforms for the life science community. [...]

Ion Channels in Drug Discovery XIX – Satellite event at BPS 2019

By |May 28th, 2019|Categories: Blog|Tags: , , , , , , , , |

Ion channels continue to rise in prominence in both academic and commercial areas. Metrion Biosciences, alongside Sophion Bioscience, Nanion Technologies, Evotec and SB Drug Discovery sponsored the “Ion [...]

A summary of the Sixth Cambridge Ion Channel Forum

By |May 3rd, 2019|Categories: Blog|Tags: , , , , , , , , , |

AstraZeneca and Metrion Biosciences again joined forces on April 9 to co-host the 6th Cambridge Ion Channel Forum, held at the Milstein building at Granta Park. The event [...]

Go to Top